TO: Mayor and Commissioners
FROM: Jeffrey L. Oris, CEcD, Assistant City Manager
THROUGH: Terrence R. Moore, ICMA-CM
DATE: August 19, 2024
Title
APPROVAL OF A POLICY FOR THE USE OF OPIOID LITIGATION SETTLEMENT FUNDS
Body
Recommended Action:
Recommendation
Approve the proposed policy for the City's use of opioid litigation funds
Body
Background:
The City of Delray Beach, in addition to other municipalities and counties located throughout the the State of Florida, has experienced the devastating effects of the opioid epidemic which arose as a result of the manufacture, distribution, and over-prescribing of opioid analgesics and resulted in opioid overdoses, addictions, and in many cases, death. In response to this epidemic, and to hold manufacturers and distributors of prescription opioids accountable for their respective contributions to the opioid crisis, legal action was filed by the State of Florida and a number of Florida cities and counties seeking damages from the resulting opioid epidemic. As a result of the Opioid Litigation, several named defendants agreed to payment of proceeds to settle various claims, much of which will be distributed over multiple years as part of a global settlement. The City of Delray Beach is expected to receive distributions from the Opioid Litigation settlements. This policy will govern the basics of the receipt of such funds.
City Attorney Review:
City Attorney has reviewed and comments have been incorporated into the proposed policy.
Funding Source/Financial Impact:
An unknown total amount of funds will be received over the next 16 years. During the past 2 years the City has received the following amounts:
|
Opioid Settlement Revenue |
Acct. No.001-223-008 |
|
|
|
|
|
|
Date |
Amount Received |
Received From |
|
12/20/2023 |
$ 21,928.79 |
Sum of Distributors Year 2 |
|
12/20/2023 |
$ 16,283.47 |
Sum of Janssen Year 2 |
|
12/20/2023 |
$ 8,267.69 |
Sum of Teva Year 2 |
|
12/20/2023 |
$ 4,943.04 |
Sum of Allergan Year 2 |
|
12/20/2023 |
$ 9,892.75 |
Sum of CVS Year 2 |
|
12/20/2023 |
$ 13,982.96 |
Sum of Walgreens Year 2 |
|
12/20/2023 |
$ 89,163.21 |
Sum of Walmart Year 1 (only Year) |
|
|
$ 164,461.91 |
|
|
|
|
|
|
12/6/2022 |
$ 25,773.39 |
Sum of Distributions Year 1&2 |
|
12/6/2022 |
$ 26,861.91 |
Sum of Janssen Year 1 |
|
12/6/2022 |
$ 17,031.70 |
Sum of Teva Year 1 |
|
12/6/2022 |
$ 2,528.49 |
Sum of Allergan Year 1 |
|
12/6/2022 |
$ 1,184.55 |
Sum of CVS Year 1 |
|
12/6/2022 |
$ 1,712.32 |
Sum of Walgreens Year 1 |
|
|
$ 75,092.36 |
|
|
|
|
|
|
Total |
$ 239,554.27 |
|
Timing of Request:
Approval will give the CIty a process by which it can decide how to spend Opioid Litigation Funds.